Diprophylline
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
Trade names | Lufyllin |
Other names | 7-(2,3-Dihydroxy-propyl)theophylline |
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a682494 |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.843 |
Chemical and physical data | |
Formula | C10H14N4O4 |
Molar mass | 254.246 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
Diprophylline (INN)[1] or dyphylline (USAN) (trade names Dilor, Lufyllin), is a xanthine derivative with bronchodilator and vasodilator effects. It is used in the treatment of respiratory disorders like asthma, cardiac dyspnea, and bronchitis. It acts as an adenosine receptor antagonist and phosphodiesterase inhibitor.[2][3]
See also[]
- Xanthine
References[]
- ^ "International Non-Proprietary Names. Recommended International Non-Proprietary Names (Rec. I.N.N.): List 1" (PDF). World Health Organization. 1955. p. 188.
- ^ Schwabe U, Ukena D, Lohse MJ (September 1985). "Xanthine derivatives as antagonists at A1 and A2 adenosine receptors". Naunyn-Schmiedeberg's Archives of Pharmacology. 330 (3): 212–21. doi:10.1007/bf00572436. PMID 2997628. S2CID 12190457.
- ^ Iancu L, Shneur A, Cohen H (1979). "Trials with xanthine derivatives in systemic treatment of psoriasis". Dermatologica. 159 (1): 55–61. doi:10.1159/000250562. PMID 225216.
Drugs for obstructive airway diseases: asthma/COPD (R03) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Adrenergics, inhalants |
| ||||||||
Glucocorticoids |
| ||||||||
Anticholinergics/ muscarinic antagonist |
| ||||||||
Mast cell stabilizers |
| ||||||||
Xanthines |
| ||||||||
Eicosanoid inhibition |
| ||||||||
Others/unknown |
| ||||||||
Combination products |
| ||||||||
|
Purine receptor modulators | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Receptor (ligands) |
| ||||||||||
Transporter (blockers) |
| ||||||||||
Enzyme (inhibitors) |
| ||||||||||
Others |
| ||||||||||
See also: Receptor/signaling modulators |
Stimulants | |
---|---|
Adamantanes |
|
Adenosine antagonists |
|
Alkylamines |
|
Ampakines | |
Arylcyclohexylamines |
|
Benzazepines |
|
Cathinones |
|
Cholinergics |
|
Convulsants |
|
Eugeroics |
|
Oxazolines |
|
Phenethylamines |
|
Phenylmorpholines |
|
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams |
|
Tropanes |
|
Tryptamines | |
Others |
|
ATC code: N06B |
Phosphodiesterase inhibitors | |
---|---|
PDE1 |
|
PDE2 |
|
PDE3 |
|
PDE4 |
|
PDE5 |
|
PDE7 | |
PDE9 |
|
PDE10 |
|
PDE11 | |
Non-selective |
|
Unsorted |
|
See also: Receptor/signaling modulators |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Adenosine receptor antagonists
- Diols
- Phosphodiesterase inhibitors
- Xanthines
- Respiratory system drug stubs
Hidden categories:
- ECHA InfoCard ID from Wikidata
- Drugboxes which contain changes to watched fields
- All stub articles